Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers

Journal of Nuclear Medicine

Volumn 39, Issue 11, 1998, Pages 1850-1856

  De Geeter, Frank ^a   Caveliers, Vicky ^a   Pansar, Ingrid ^a   Bossuyt, Axel ^a   Franken, Philippe R ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

15 (p iodophenyl) 3 R,S methyl pentadecanoic acid; Biodistribution; Glucose

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CARBOHYDRATE; FATTY ACID; PROTEIN; TRACER;

ARTICLE; DIETARY INTAKE; DRUG DISCRIMINATION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HUMAN; INSULINEMIA; LIVER; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ADULT; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; FASTING; FATTY ACIDS; GLUCOSE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MYOCARDIUM; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031796664     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
2. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022-1030.
3. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
4. 123I beta-methyl iodophenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
5. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
6. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996;37:718-722.
7. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med 1986;12:S39-S44.
8. Knapp FF Jr, Goodman MM, Kirsch G. Iodine-123-labeled DMIPP: a useful new agent to evaluate myocardial fatty acid uptake. J Nucl Med 1986;27:521-531.
9. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-1050.
10. Machulla H-J. Carrier-mediated transport of fatty acids causes mismatch between measurements of perfusion and fatty acid metabolism in the myocardium [Letter]. J Nucl Med 1996;37:547.
11. De Geeter F. BMIPP and flow tracers in myocardial hypoperfusion [Letter]. J Nucl Med 1997;38:1171.
12. 125I 15-(p-iodo-phenyl)3-(R,S)-methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
13. 123I-radioiodination of 15(p-1-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987;13:159-160.
14. Bax JJ, Veening MA, Visser FC, et al. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging: a comparative study using different protocols. Eur J Nucl Med 1997;24:35-41.
15. De Geeter F, Franken PR, Defrise M, Andries H, Saelens E, Bossuyt A. Optimal collimator choice for sequential iodine-123 and technetium-99m imaging. Eur J Nucl Med 1996;23:768-774.
16. 201T1 myocardial SPECT: presentation of method. Nuklearmedizin 1986; 25:128-133.
17. 11C]beta-methylheptadecanoic acid. J Nucl Med 1994;35:496-503.
18. Vyska K, Meyer W, Stremmel W, et al. Fatty acid uptake in normal human myocardium. Circ Res 1991;69:857-870.
19. Bianco JA, Elmaleh DR, Leppo JA, et al. Effect of glucose and insulin infusion on the myocardial extraction of a radioiodinated methyl-substituted fatty acid. Eur J Nucl Med 1986;12:120-124.
20. Schelbert HR, Henze E, Schon HR, et al. Carbon-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 1983;105:492-504.
21. Stryer L. Fatty acid metabolism. In: Stryer L, Biochemistry, 3rd ed. New York: W.H. Freeman and Company; 1988:469-493.
22. Kurata C, Wakabayashi Y, Shouda S, et al. Influence of blood substrate levels on myocardial kinetics of iodinc-123-BMIPP. J Nucl Med 1997;38:1079-1084.
23. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996;37:757-761.
24. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990;31:1749-1756.
25. Schwaiger M, Hicks R. Regional heterogeneity of cardiac substrate metabolism? [Editorial]. J Nucl Med 1990;31:1757-1760.
26. Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997;38:175-180.
27. Nellis SH, Liedtke AJ, Renstrom B. Distribution of carbon flux within fatty acid utilization during myocardial ischemia and reperfusion. Circulation Res 1991;69:779-790.
28. 123I-BMIPP). Eur J Nucl Med 1996;23:383-389.